High Resolution, High-speed Multimodal Ophthalmic Imaging

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentre Hospitalier National d'Ophtalmologie des Quinze-Vingts

About this trial

Knowledge of the pathogenesis of ocular conditions, a leading cause of blindness, has benefited greatly from recent advances in ophthalmic imaging. However, current clinical imaging systems are limited in resolution, speed, or access to certain structures of the eye.

The use of a high-resolution imaging system improves the resolution of ophthalmoscopes by several orders of magnitude, allowing the visualization of many microstructures of the eye: photoreceptors, vessels, nerve bundles in the retina, cells and nerves in the cornea.

The use of a high-speed acquisition imaging system makes it possible to detect functional measurements such as the speed of blood flow. The combination of data from multiple imaging systems to obtain multimodal information is of great importance for improving the understanding of structural changes in the eye during a disease.

The purpose of this project is to observe structures that are not detectable with routinely used systems.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

People over 18

Patient with a pathology affecting the eye or healthy volunteer

Participant who signed the consent

Beneficiaries of the health insurance

Disqualifiers

Patients with a history of photosensitivity.

Patients who have just received a photodynamic therapy treatment (

Patients taking drugs with photosensitivity as a side effect.

Persons with pacemakers or other implanted electronic medical device

Trial design

Design model

Single group

Treatments tested in this trial

  • High-resolution retinal imaging through adaptive optics

    Device

    The protocol consists of performing retinal imaging using full-field optical coherence tomography. The participant is asked to put his forehead against the temple supports and his chin on a chin rest. The subject will be asked to fix a test pattern in the form of a cross. The pattern is positioned according to the desired eccentricity with respect to the fovea. The actual acquisition lasts a few seconds, possibly repeated to cover the field of the desired eye. The acquisition protocol depends on the subjects, their pathology and the system used; the area examined will be modified on a case by case basis. The total duration of each exam can be estimated at less than half an hour, with frequent breaks.

  • High-resolution retinal imaging through holographic systems

    Device

    The protocol consists of performing retinal imaging using a laser Doppler holography. For each system, the participant is asked to put his forehead against the temple supports and his chin on a chin rest. The subject will be asked to fix a test pattern in the form of a cross. The pattern is positioned according to the desired eccentricity with respect to the fovea. The actual acquisition lasts a few seconds, possibly repeated to cover the field of the desired eye. The acquisition protocol depends on the subjects, their pathology and the system used; the area examined will be modified on a case by case basis. The total duration of each exam can be estimated at less than half an hour, with frequent breaks.

Treatment groups

1,200 Participants
are divided into 1 treatment group
Group A: High-resolution retinal imaging through adaptive opticsExperimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Visualization of a structure of interest and measuring the short-term and long-term reproducibility of the data collected compared to routine systems

Obtain the visualization of a structure of interest or obtain a measurement that are not detectable with the systems used routinely by analyzing images with image analysis software dedicated by a multidisciplinary group including doctors and physicists, assisted by computer scientists The visualization of the structure of interest in at least one area of the image will be considered the main criterion of success.

Time frame
From date of inclusion until the date of last documented progression , assessed up to 5 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.